6 chapters across the catalog
Joe Biden Nuremberg Trials Speech, University of Connecticut
President Biden delivered a speech at the University of Connecticut's Dodd Center for Human Rights, invoking the Nuremberg trials and the importance of facing the truth. The hosts contrast his rhetoric about the Nuremberg Code with his administration's current vaccine mandates.
The hosts evaluate current vaccination policies against the ten points of the Nuremberg Code, which was established following Nazi medical experiments. They discuss potential violations regarding voluntary consent, animal trials, and the right of subjects to terminate their participation in a medical experiment.
Dr. Francis Collins, NIH Vaccine Strategy and "Dummy Placebos"
Dr. Francis Collins, head of the National Institutes of Health (NIH), is leading a massive effort to launch four vaccine trials involving 30,000 volunteers each starting in July 2020. Collins noted that trials must occur in areas where the virus is actively spreading, specifically targeting "red states" that opened early. A reference to "dummy placebos" in his description of the trial methodology raised questions about the terminology used for control groups.
The first human trials for a COVID-19 vaccine have commenced in South Africa, involving a significant number of participants. The move has sparked criticism regarding the ethics of testing new pharmaceuticals on African populations. Skeptics reference past controversies involving international vaccine programs in India and Africa as a reason for public distrust.
President Trump announced that human trials for a coronavirus vaccine began in record time, just eight weeks after the genetic sequence was published. The hosts discuss "Gene 133" and CRISPR technology, suggesting the new treatment is not a traditional vaccine but a genetic insertion designed to create protective plasma. They question the lack of detailed media reporting on the mechanics of these new medical technologies.
Australian Swine Flu Vaccine Trials, CSL Biotherapy
Human trials for a swine flu vaccine have commenced in Australia at the Royal Adelaide Hospital, involving hundreds of adults and children. CSL Limited is conducting the tests, which include double-dose injections for infants as young as six months to determine efficacy before a planned mass rollout.
